Oliclinomel N7-1000e

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Oliclinomel N7-1000e, is a nutrition supplement presented as a intravenous formulation for clinical use. It is intended to support metabolic and nutritional needs in patients requiring parenteral nutrition.

GNH USA supplies Oliclinomel N7-1000e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Oliclinomel N7-1000e is used as part of parenteral nutrition regimens to address amino‑acid deficiencies. - Critical illness: helps maintain nitrogen balance and supports protein synthesis. - Post‑operative recovery: contributes to wound healing and tissue repair. - Long‑term home parenteral nutrition: provides essential amino acids for patients unable to meet needs orally. - Severe malnutrition: assists in restoring lean body mass. - Metabolic stress states: aids in stabilising metabolic parameters.

Adverse reactions are generally related to the intravenous route and the amino‑acid composition.

Common Side Effects: - Mild infusion‑related erythema - Transient increase in serum ammonia - Slight elevation of liver enzymes - Pruritus at the infusion site - Nausea or mild gastrointestinal discomfort - Headache

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction - Acute hemolysis - Severe electrolyte disturbances - Thromboembolic events linked to catheter use - Sepsis related to infusion line infection - Persistent hypotension during infusion

When using Oliclinomel N7-1000e, clinicians should observe standard parenteral nutrition safety measures. - Patient assessment: evaluate renal and hepatic function before initiation. - Infusion rate: administer according to recommended speed to avoid metabolic overload. - Compatibility: verify compatibility with other IV solutions and medications. - Monitoring: regularly check electrolytes, blood gases, and nitrogen balance. - Contraindications: avoid in patients with known hypersensitivity to any amino‑acid component. - Store at ambient temperature: keep in original packaging, protect from light and moisture.

Oliclinomel N7-1000e may interact with other intravenous therapies and medications that affect amino‑acid metabolism.

Major Interactions (Avoid): - High‑dose corticosteroids: may increase protein catabolism. - Certain anticonvulsants (e.g., phenobarbital): can alter amino‑acid plasma levels.

Moderate Interactions (Monitor Closely): - Loop diuretics: may exacerbate electrolyte shifts. - Insulin therapy: requires careful glucose monitoring due to gluconeogenic substrates. - Parenteral lipid emulsions: adjust amino‑acid dosing to maintain nitrogen balance. - Renal replacement therapies: may remove amino acids, affecting dosing. - Vitamin B6 supplementation: high doses can modify amino‑acid metabolism.